Search Within

Radiology, Department of

  1. "Clinical Nuclear Medicine"
Formats
  1. Journal Article (64)
  2. Miscellaneous (6)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (68)
  2. Department of Medicine (15)
  3. Sloan Kettering Institute Postdocs (15)
  4. Body Imaging Service (13)
  5. GSK Faculty (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (11)

More Groups

People
  1. Gary Ulaner (23)
  2. Steven Larson (11)
  3. Jorge Carrasquillo (10)
  4. Neeta Pandit-Taskar (10)
  5. Ravinder Grewal (7)
  6. Sonia Mahajan (7)

More People

Years
  1. 2025 (2)
  2. 2024 (2)
  3. 2023 (1)
  4. 2022 (1)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publications
  1. Clinical Nuclear Medicine (72)
Publishers
  1. Lippincott Williams & Wilkins (72)

Results (72)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FAP-targeted SPECT/CT and PET/CT imaging for breast cancer patients
    Review

    McGale, J.; Khurana, S.; Howell, H.; Nakhla, A.; Roa, T.; Doshi, P.; Shirini, D.; Huang, A.; Duong, P.; Backhaus, P.; more...
    Clinical Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Voxel-based dosimetry predicts local tumor progression post (90)Y radiation segmentectomy of colorectal liver metastases
    Journal Article

    Dimopoulos, P. M.; Sotirchos, V. S.; Dunne-Jaffe, C.; Petre, E. N.; Gonen, M.; Zhao, K.; Kirov, A. S.; Crane, C.; D'Angelica, M.; Connell, L. C.; more...
    Clinical Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Tumors affect the metabolic connectivity of the human brain measured by 18F-FDG PET
    Journal Article

    Pasquini, L.; Jenabi, M.; Graham, M.; Peck, K. K.; Schòˆder, H.; Holodny, A. I.; Krebs, S.
    Clinical Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Hepatic PSMA-avid postradiation inflammation
    Miscellaneous

    Silveira, P.; Razmaria, A.; Yeh, R.
    Clinical Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • A phase 1, open-label, dose-ascending study to evaluate the safety and tolerability of the therapeutic radiopharmaceutical (131)I-MIP-1095 for the treatment of metastatic castration-resistant prostate cancer
    Journal Article

    Laccetti, A. L.; Bodei, L.; O'Donoghue, J. A.; Weber, W. A.; Morris, M. J.
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • ACR-ACNM-ASTRO-SNMMI practice parameter for Lutetium-177 (Lu-177) DOTATATE therapy
    Guidelines

    Love, C.; Desai, N. B.; Abraham, T.; Banks, K. P.; Bodei, L.; Boike, T.; Brown, R. K. J.; Bushnell, D. L.; DeBlanche, L. E.; Dominello, M. M.; more...
    Clinical Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • Assessment of central nervous system lymphoma based on CXCR4 expression in vivo using (68)Ga-pentixafor PET/MRI
    Journal Article

    Starzer, A. M.; Berghoff, A. S.; Traub-Weidinger, T.; Haug, A. R.; Widhalm, G.; Hacker, M.; Rausch, I.; Preusser, M.; Mayerhoefer, M. E.
    Clinical Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • (18)F-FDG PET/CT helps differentiate peripheral nerve myeloid sarcoma from a presumed benign nerve sheath tumor
    Miscellaneous

    Das, J. P.; Riedl, C. C.; Ulaner, G. A.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Extramedullary myeloma of the uterus on (18)F-FDG PET/CT: A rare manifestation of multiple myeloma
    Miscellaneous

    Causa Andrieu, P. I.; Das, J. P.; Woo, S.; Ryan, R.; Akin, O.; Ulaner, G. A.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Acute aortic dissection initially suspected on (18)F-FDG PET/CT
    Miscellaneous

    Ulaner, G. A.; Muehlbauer, S.; Goldberg, Z.
    Clinical Nuclear Medicine (2020)

    Fulltext@MSK | Save